SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (3045)3/6/2015 6:44:26 AM
From: Doc Bones   of 3158
 
FWIW - Jim Cramer obviously has a big audience - This was on Cramer's Thurs 3/5 Mad Money show. Part of his larger thesis: We are NOT in a bubble; well run companies may be undervalued. - Doc

In the biotech space, Cramer highlighted Pharmacyclics (PCYC), which popped 10% on a takeover bid from Abbvie (ABBV), a stock which Cramer owns for his charitable trust, Action Alerts PLUS. Pharmacyclics seemed like a bubble yesterday, up 88% so far this year, but today a smart company swooped in and took it to a whole new level. Could other Cramer faves like Isis Pharmaceuticals (ISIS), Receptos (RCPT) or BioMarin (BMRN) be next?
thestreet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News